Berends Tamara, van Meijel Berno, Nugteren Willem, Deen Mathijs, Danner Unna N, Hoek Hans W, van Elburg Annemarie A
Altrecht Eating Disorders Rintveld, Wenshoek 4, 3705 WJ, Zeist, The Netherlands.
Department of Health, Sports & Welfare, Cluster Nursing, Inholland University of Applied Sciences, Research Group Mental Health Nursing, Amsterdam, The Netherlands.
BMC Psychiatry. 2016 Sep 8;16(1):316. doi: 10.1186/s12888-016-1019-y.
Relapse is common among recovered anorexia nervosa (AN) patients. Studies on relapse prevention with an average follow-up period of 18 months found relapse rates between 35 and 41 %. In leading guidelines there is general consensus that relapse prevention in patients treated for AN is a matter of essence. However, lack of methodological support hinders the practical implementation of relapse prevention strategies in clinical practice. For this reason we developed the Guideline Relapse Prevention Anorexia Nervosa. In this study we examine the rate, timing and predictors of relapse when using this guideline.
Cohort study with 83 AN patients who were enrolled in a relapse prevention program for anorexia nervosa with 18 months follow-up. Data were analyzed using Kaplan-Meijer survival analyses and Cox regression.
Eleven percent of the participants experienced a full relapse, 19 % a partial relapse, 70 % did not relapse. Survival analyses indicated that in the first four months of the program no full relapses occurred. The highest risk of full relapse was between months 4 and 16. None of the variables remained a significant predictor of relapse in the multivariate Cox regression analysis.
The guideline offers structured procedures for relapse prevention. In this study the relapse rates were relatively low compared to relapse rates in previous studies. We recommend that all patients with AN set up a personalized relapse prevention plan at the end of their treatment and be monitored at least 18 months after discharge. It may significantly contribute to the reduction of relapse rates.
神经性厌食症(AN)康复患者复发很常见。平均随访期为18个月的预防复发研究发现复发率在35%至41%之间。在主要指南中,普遍达成的共识是,对接受AN治疗的患者进行预防复发至关重要。然而,缺乏方法学支持阻碍了预防复发策略在临床实践中的实际应用。因此,我们制定了《神经性厌食症预防复发指南》。在本研究中,我们考察了使用该指南时的复发率、复发时间及预测因素。
对83名AN患者进行队列研究,这些患者参加了为期18个月随访的神经性厌食症预防复发项目。使用Kaplan-Meijer生存分析和Cox回归分析数据。
11%的参与者经历了完全复发,19%的参与者经历了部分复发,70%的参与者未复发。生存分析表明,在项目的前四个月没有发生完全复发。完全复发的最高风险在第4至16个月之间。在多变量Cox回归分析中,没有变量仍然是复发的显著预测因素。
该指南为预防复发提供了结构化程序。在本研究中,与先前研究中的复发率相比,复发率相对较低。我们建议所有AN患者在治疗结束时制定个性化的预防复发计划,并在出院后至少监测18个月。这可能会显著有助于降低复发率。